A Clinical Trial of Ifinatamab Deruxtecan in People With Advanced Esophageal Cancer (MK-3475-06F)

NCT07405151 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Oesophageal Squamous Cell Carcinoma

Interventions

BIOLOGICAL: I-DXd
DRUG: Rescue Medication

Sponsor

Merck Sharp & Dohme LLC

Collaborators

[object Object]